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Summary
L4 and L22, proteins of the large ribosomal subunit,
contain globular surface domains and elongated ‘ten-
tacles’ that reach into the core of the large subunit to
form part of the lining of the peptide exit tunnel. Muta-
tions in the tentacles of L4 and L22 confer macrolide
resistance in a variety of pathogenic and non-
pathogenic bacteria. In Escherichia coli, a Lys-to-Glu
mutation in L4 and a three-amino-acid deletion in the
L22 had been reported. To learn more about the roles
of the tentacles in ribosome assembly and function,
we isolated additional erythromycin-resistant E. coli
mutants. Eight new mutations mapped in L4, all within
the tentacle. Two new mutations were identiﬁed in
L22; one mapped outside the tentacle. Insertion muta-
tions were found in both genes. All of the mutants
grew slower than the parent, and they all showed
reduced in vivo rates of peptide-chain elongation and
increased levels of precursor 23S rRNA. Large inser-
tions in L4 and L22 resulted in very slow growth and
accumulation of abnormal ribosomal subunits. Our
results highlight the important role of L4 and L22 in
ribosome function and assembly, and indicate that a
variety of changes in these proteins can mediate mac-
rolide resistance.
Introduction
Many antibiotics, including members of the macrolide
family, target the bacterial ribosome (Poehlsgaard and
Douthwaite, 2005). Macrolide antibiotics bind to the bac-
terial large ribosomal subunit near the peptidyltransferase
centre (PTC) at the beginning of the peptide exit tunnel
(Schlunzen et al., 2001; Hansen et al., 2002a; Tu et al.,
2005). Binding is thought to prevent progression of the
growing peptide chain through the exit tunnel (Weisblum,
1995; Hansen et al., 2003; Tenson et al., 2003), leading to
dissociation of the peptidyl tRNAfrom the ribosome (Men-
ninger and Otto, 1982; Lovmar et al., 2004). Macrolide-
resistant strains can arise via a number of different
mechanisms, including methylation ofA2058 in 23S rRNA
by erm methyltransferases (Weisblum, 1995); mutation of
23S rRNA residues A2058, A2059 or A2062 (Vester and
Douthwaite, 2001; Franceschi et al., 2004); and special-
ized efflux pumps (Poole, 2007).
Mutations in ribosomal proteins L4 and L22 can also
cause macrolide resistance (Wittmann et al., 1973; Pardo
and Rosset, 1977; Chittum and Champney, 1994; France-
schi et al., 2004). Like many other ribosomal proteins, L4
and L22 have globular domains on the surface of the
ribosome and long tentacles that extend into the core of
the ribosome. The tips of these extended loops form part
of the lining of the exit tunnel (Ban et al., 2000; Nissen
et al., 2000; Schuwirth et al., 2005), which is otherwise
almost entirely lined by RNA (Ban et al., 2000). In bacte-
rial species other than Escherichia coli, a variety of
macrolide-resistant mutations in L4 and L22 have been
identiﬁed (Franceschi et al., 2004), most of which map to
the tentacles of L4 and L22. In E. coli only two
erythromycin-resistant (ery-R) mutants have been char-
acterized: strain N281 contains a deletion removing Met–
Lys–Arg corresponding to codons 82–84 of L22, and
strain N282 contains a change from lysine to glutamine at
codon 63 of L4 (Apirion, 1967; Wittmann et al., 1973;
Chittum and Champney, 1994).
Ribosomes from E. coli strain N282, containing the L4
mutation, bind erythromycin poorly, while ribosomes from
N281, containing the mutant L22 protein, can still bind the
antibiotic (Chittum and Champney, 1994). Furthermore,
50S subunit assembly is inhibited in the L22 mutant at
high erythromycin concentrations, but assembly is unaf-
fected in the L4 mutant (Chittum and Champney, 1995).
The L4 mutant appears to reduce peptidyltransferase
activity and increase levels of frameshifting, missense
decoding, and readthrough of stop codons; peptidyltrans-
ferase activity and decoding are unaffected in the L22
mutant (Wittmann et al., 1973; O’Connor et al., 2004).
Based on erythromycin binding and cryo-EM data of the
two known E. coli mutants, it was proposed that the
L4 mutation narrows the peptide exit tunnel so that
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widens the tunnel so that erythromycin binds but the
nascent polypeptide is able to pass by (Gabashvili et al.,
2001).
Given the variety of L4- and L22-mediated ery-R muta-
tions observed in other species of bacteria (Franceschi
et al., 2004), we reasoned that it should be possible to
isolate additional mutations in the E. coli protein genes. If
so, then such mutants could be used to further character-
ize the role of L4 and L22 (particularly, their tentacles) in
ribosome assembly and function, as well as the mecha-
nism(s) of macrolide resistance. Starting with E. coli strain
AB301 (the parent of the two canonical ery-R mutant
strains), we selected colonies that could grow on
erythromycin.As predicted, we isolated novel mutations in
these genes, including ﬁve missense and three insertion
mutations in the L4 gene and two insertion mutations in
the L22 gene.All but one mutation, a 6 bp insertion in L22,
mapped within the tentacles of L4 and L22.
We have analysed the new E. coli L4 and L22
mutants, and observed effects on growth rate, peptide
elongation rate and 23S rRNA processing. Some of the
mutants also accumulated intermediate 45S particles.
Our results not only provide insights into the mechanism
of erythromycin resistance, but also highlight the
important role of L4 and L22 in ribosome function and
assembly.
Results
Identiﬁcation of novel mutations in L4 and L22 genes
We selected spontaneous ery-R mutants from E. coli
strain AB301 by spreading cells from overnight cultures
on plates containing erythromycin at 150 or 200 mgm l -1.
About half of the colonies (33 out of 63) had a mutation in
either L4 or L22. Because only two of the mutations were
isolated more than once (Table 1, column 1), we have
Table 1. Properties of AB301 and ery-R derivatives.
Strain
#o f
isolates
a
Doubling
time
(min)
b
Max.
ery
resist.
(mg ml
-1)
c
Max.
spira
resist.
(mg ml
-1)
d
Max.
tylosin
resist.
(mg ml
-1)
e
b-gal
induction
lag time
(s)
f
45S
particles?
g
Fraction
pre-23S
h
Normalized
14C-Ery
= bound
i
–Ery +Ery –Ery +Ery –Ery +Ery
AB301 30 (1.0) < 0.1 < 1.0 1.0 130 – – 0.03 1.00 0.47
L4-Q62K 1 (200) 57 (1.9) 83 1.5 3.0 > 6.0 160 (1.2) – – 0.12 0.03 0.04
L4-K63E
(N282)
1 (150) 55 (1.8) 70 2.0 3.0 > 6.0 180 (1.4) – – 0.05 0.02
L4-G66S 1 (200) 36 (1.2) 70 0.5 1.5 2.0 140 (1.1) – – 0.08 0.56 0.19
L4-G66D 2 (150) 47 (1.6) 50 0.5 3.0 > 6.0 155 (1.2) – – 0.06 0.14 0.11
L4-G66R 1 (150) 65 (2.2) 78 1.0 3.0 > 6.0 160 (1.2) – – 0.11 0.01 0.04
L4-G66C 1 (200) 73 (2.4) 137 > 4.0 > 4.0 > 6.0 150 (1.2) – ++ 0.14 0.08 0.04
L4-56/6 1 (200) 103 (3.4) 115 2.0 3.0 > 6.0 200 (1.5) ++0.16 0.01 0.01
L4-63/4 1 (150) 77 (2.6) 88 1.5 3.0 > 6.0 155 (1.2) ++0.14 0.01 0.00
L4-72/6 1 (150) 121 (4.0) 122 > 4.0 > 4.0 > 6.0 200 (1.5) ++0.17 0.00 0.01
L22-DMKR
(N281)
0 50 (1.7) 50 1.5 1.5 4.0 150 (1.2) – – 0.74 0.42
L22-99/15 7 (150
and 200)
99 (3.3) 104 > 4.0 3.0 > 6.0 165 (1.3) +++ +++ 0.22 0.14 0.03
L22-105/2 1 (200) 59 (2.0) 57 2.5 3.0 > 6.0 150 (1.2)  ++ 0.12 0.68 0.19
a (column 1). In some cases we could not exclude that mutations found more than once arose from a single mutational event, so the numbers
indicate the minimum number of isolates for each mutation. The values in parentheses indicate the concentration of erythromycin at which the
mutant was isolated. L22-99/15 mutations were isolated at both 150 and 200 mgm l
-1; three isolates were analysed, two from 150 mgm l
-1
erythromycin plates, and one isolated at 200 mgm l
-1. Their growth properties were indistinguishable.
b (column 2). Cells were grown at 37°C in LB. Values in parentheses indicate the growth rate normalized to the growth rate of AB301. Where
indicated (+Ery), erythromycin was added to the concentration of the antibiotic used for the original isolation. BecauseAB301 does not grow at 150
or 200 mgm l
-1 erythromycin, we studied its growth at 50 mgm l
-1, at which concentration it grew with a 95 min doubling time. Growth rates for each
mutant were calculated for at least three cultures. For more complete data, including standard errors of the mean, see Fig. S1.
c–e (columns 3–5) Growth on LB plates containing various concentrations of antibiotics was scored as visible growth after 2 days at 37°C.
f (column 6). Values in parentheses indicate the lag time normalized to the AB301 value. For more details, see Fig. 2 and Experimental
procedures.
g (column 7). The relative amounts of 45S particles are indicated as a range between no (–) and high (+++) amounts. Where indicated (+Ery),
erythromycin was added to the concentration of the antibiotic used for the original isolation. The wild-type cells were grown at a sublethal (75
mgm l
-1) concentration of erythromycin. For more details, see Fig. 3.
h (column 8). The fraction of pre-23S rRNA was calculated as described in Experimental procedures.
i (column 9). The amount of
14C-Ery (cpm) bound to ribosomes isolated from cells grown in the absence (–Ery) or presence (+Ery) was normalized
to the amount bound to the wild-type parent ribosomes prepared from cells grown without erythromycin. The wild-type cells were grown at a
sublethal (75 mgm l
-1) concentration of erythromycin. For more details, see Fig. S4.
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erythromycin-resistance mutations.
In L4, all of the mutations mapped to the extended loop
(Fig. 1A and B). Of the ﬁve new missense mutations, four
were in the glycine codon at position 66 (L4-G66S,
-G66C, -G66R, and -G66D) and one was in codon 62,
causing a Gln-to-Lys change (L4-Q62K). In addition, we
isolated the canonical mutation K63E (strain N282). Three
large insertion mutations were also identiﬁed in L4. The
insertions after codons 56 and 72 were 18 bp direct
repeats of the DNA sequence immediately upstream
(called L4-56/6 and L4-72/6, respectively), while the inser-
tion within codon 63 was a 12 bp repeat (called L4-63/4).
Of the L22 mutations, one was in the extended loop
(45 bp direct repeat insertion after codon 99, named L22-
99/15), while one (6 bp direct repeat insertion after codon
105, called L22-105/2) was in the globular domain
(Fig. 1C and D). We did not isolate the canonical DMKR
mutant (strain N281). It is interesting that we isolated the
L22-99/15 mutations seven times. Because cells carrying
that mutation exhibited especially interesting properties
(described below), we characterized three of the indepen-
dent isolates; their phenotypes were indistinguishable
(see, e.g. Fig. S1).
Growth of L4 and L22 mutants in the presence and
absence of macrolides
The growth rates of the ery-R L4 and L22 mutants and the
wild-type parent (AB301) were determined in LB liquid
medium at 37°C with and without erythromycin (Table 1,
column 2, and Fig. S1). In the absence of erythromycin,
Fig. 1. Mutations in L4 and L22 conferring erythromycin resistance in E. coli.
A. Structure model of L4 (derived using CHIMERA from PDB ﬁle A2WB) showing locations of missense and insertion mutations in the tentacle
of L4. Alpha helices are shown in green, and beta sheets are shown in purple.
B. Positions in the L4 gene of mutations conferring erythromycin resistance. Changes are indicated in red.
C. Structure model of L22 (derived using CHIMERA from PDB ﬁle A2WB) showing locations of deletion and insertion mutations in L22.
D. Positions in the L22 gene of mutations conferring erythromycin resistance. Changes are indicated in red.
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All of the mutant strains grew more slowly, with doubling
times up to four times the wild-type doubling time. Except
for L22-105/2, the insertion mutant strains were especially
slow. Addition of erythromycin further slowed the growth
of all of the L4 missense mutant strains, as well as two of
the L4 insertion mutants (Table 1, column 2, and Fig. S1).
The L22 insertion mutants and L4-72/6 grew about as well
when erythromycin was included in the media. None of
the mutants exhibited signiﬁcant temperature sensitivity
(data not shown).
Although selected at 150 or 200 mgm l -1 erythromycin,
the mutant strains were resistant on LB plates to at least
500 mgm l -1 erythromycin; several were resistant to
4m gm l -1 erythromycin (Table 1, column 3). However, as
expected from the liquid growth analysis, most of the
mutants grew more slowly at even the lowest tested con-
centration of the antibiotic (100 mgm l -1). We also tested
the mutants for cross-resistance to other macrolide anti-
biotics, including spiramycin, tylosin and troleandomycin.
Not surprisingly, all of the mutant strains showed
increased resistance to these other macrolides (Table 1,
columns 4 and 5, and data not shown).
Reversion of L4 and L22 large insertion mutants grown
in the absence of erythromycin
We observed that the insertion mutants (except for
L22-105/2) grew much better after they had been grown
overnight in antibiotic-free liquid media. Furthermore,
when we streaked these mutant strains on LB and
LB + erythromycin plates, we observed heterogeneous
colony sizes on antibiotic-free plates (Fig. S2). To learn
the cause of the faster-growing cells, we ampliﬁed and
then sequenced the L4 and L22 genes from large and
small colonies from each mutant. We found that the large
colonies had reverted to the wild-type L4 and L22
sequences and regained sensitivity to erythromycin, while
small colonies had retained the original insertions and
erythromycin resistance. Thus, it appears that the large
insertions were frequently removed from the L4 or L22 by
a secondary mutation event that restored the wild-type
sequence and growth rate.
Rate of translation elongation in L4 and L22
mutant strains
The reduced growth rates of the mutants suggest that
ribosome function and/or assembly might be affected by
mutations in L4 and L22. To investigate the effect on
ribosomefunction,wemeasuredtheinvivorateofpeptide-
chain elongation by measuring the time between
isopropylthio-D-galactoside (IPTG) induction of transcrip-
tion of the lacZ gene and the appearance of
b-galactosidase activity above the basal level (Coffman
et al., 1971). The parent strain had an induction lag of
about130 s(Table 1,column6,andFig. 2),corresponding
toanelongationrateof7.9aminoacidspersecond.Mutant
strains had a lag that ranged from 140 s (7.3 aa s-1)t o
200 s (~5.1 aa s-1) (Table 1, Fig. 2, and data not shown).
Thus, the ery-R strains exhibited a decreased rate of chain
elongation that roughly correlated with the growth defect.
However, the difference is not sufficient to account for the
substantially decreased growth rates of some of the
mutants. For example, the L4 and L22 large insertion
mutant strains have growth rates up to three times as long
as that of wild type, but a b-galactosidase synthesis time
that was less than twice that of the wild-type strain. It is
important to note that this assay reﬂects the fastest rate of
peptide elongation in the cell. If a heterogeneous popula-
tion of ribosomes were present, the measured rate of
elongation would reﬂect only the rate of the ‘fastest’ ribo-
somes, which might in principle be in the minority.
Ribosomal subunit assembly defects in L4 and L22
large insertion mutants
To determine whether the slow-growth phenotype could
also be a result of defective ribosome assembly, we analy-
sed ribosomal particles of wild-type and mutant strains
using sucrose gradient analysis. Crude ribosomes from
Fig. 2. b-Galactosidase induction lag times. Cells growing in
minimal medium were induced with IPTG. Aliquots were removed
and assayed at various times after induction (see Experimental
procedures) to detect the time at which the enzyme activity
increased above the basal level. Results for the wild-type parent
and several of the mutants are shown. The y-axis represents
arbitrary b-galactosidase activities, but the x-axis is the same for all
the strains.
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sucrose gradients under conditions favouring dissociation
of ribosomal subunits (1 mM MgCl2, 200 mM NH4Cl). In
our initial experiments, we grew all of the ery-R mutants in
the presence of erythromycin to avoid accumulation of
revertants (described above). Under these growth condi-
tions, most of the L4 missense mutants had a proﬁle that
was very similar to the pattern for the parent strain grown
in the absence of erythromycin (Fig. 3, top, and data not
shown). However, one of the L4 missense mutants
(G66C), and all of the L4 and L22 insertion mutants, had
abnormal proﬁles, with a new peak evident between the
30S and 50S peaks (Fig. 3, top). This peak, which we call
45S, was especially prominent in the L22 large insertion
strains.
Because erythromycin has been shown to affect 50S
subunit assembly (Chittum and Champney, 1995; Usary
and Champney, 2001; Champney, 2006), we wanted to
determine whether the aberrant proﬁle was due to the
presence of the antibiotic or the mutations in L4 and L22.
The non-reverting L4-G66C strain and the stable L22-
105/2 insertion mutant were grown in LB without
erythromycin. The reverting strains were grown using an
‘erythromycin chase’ protocol (see Experimental proce-
dures) consisting of initial growth in the presence of eryth-
romycin and removal of the antibiotic, followed by growth
without erythromycin for 2–4 doublings. Under these
growth conditions, the 45S peak was diminished in L22-
105/2 and disappeared from L4–66C proﬁles (Fig. 3,
bottom), suggesting that for these mutants, the antibiotic
was responsible for the aberrant peak. Interestingly, we
did not observe this peak with ribosomes from AB301
grown in the presence of erythromycin: as reported pre-
viously (Usary and Champney, 2001), these wild-type
ribosomes showed a decrease in the amount of 50S com-
pared with 30S, but no evidence of an extra ‘45S’ peak
(Fig. 3).
The small aberrant peak observed with the L4 insertion
mutants L4-56/6, L4-63/4 and L4-72/6 was present at
about the same level with or without erythromycin (Fig. 3).
Moreover, the large aberrant peak was still observed
when the L22 large insertion mutant (L22-99/15) was
grown in the absence of erythromycin (Fig. 3). The results
of the sucrose gradient analysis are summarized in
Table 1 (column 7). The accumulation of incomplete 45S
particles correlates with the slow-growth phenotype of the
large insertion mutants, and indicates that ribosome bio-
genesis is severely inhibited by the presence of large
insertions in L4 and L22 independently of the erythromy-
cin effect on assembly.
Processing of pre-23S rRNA in Ery-R mutant strains
Given that many of the mutants accumulated abnormal
version(s) of the large ribosomal subunit, we investigated
whether 23S rRNA processing was affected. Precursor
23S (pre-23S) rRNA generated by RNase III cleavage of
the primary transcript is 7 nucleotides longer at the 5′ end
than mature 23S RNA (King et al., 1984). We used primer
extension analysis to determine the relative amounts of
mature and pre-23S in wild-type and mutant strains. Total
RNA extracted from cultures growing in mid-log phase
was used as template, and an oligonucleotide comple-
mentary to the region ~75 nucleotides from the 5′ end of
Fig. 3. Sucrose gradient sedimentation proﬁles of AB301 and ery-R mutants. Crude ribosomes isolated from cells grown in LB with (+Ery) or
without (–Ery) erythromycin were centrifuged through a 10–50% (w/v) sucrose gradient prepared in buffer containing 1 mM MgCl2 and 200 mM
NH4Cl. Absorption proﬁles were recorded at 260 nm. The absorption peaks of free 30S and 50S subunits are identiﬁed; aberrant ribosomal
particles are indicated by vertical arrows. Fractions from the L22-99/15 –Ery gradient used later for primer extension (Fig. 4B) are indicated.
The results for all of the mutants are summarized in Table 1, column 7.
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in all the strains, corresponding in size to mature and
pre-23S RNA (Fig. 4A). The fraction of pre-23S in the
wild-type strain was 0.03.All of the mutant strains showed
increased levels of the precursor form of 23S. The mis-
sense and short insertion mutant strains showed two- to
almost ﬁvefold increases, while the large insertion
mutants showed a more dramatic increase, ranging from
ﬁve- to sevenfold (Fig. 4A and Table 1, column 8). These
results indicate that all of the L4 and L22 mutations cor-
relate with a slower rate of rRNA processing.
The L22-99/15 mutant showed the highest level of pre-
23S rRNA (22%), so we analysed it in more detail. To
determine which ribosomal particles contain pre-23S, we
extracted RNA from the fractions of the high-salt and
low-Mg gradient of L22-99/15 ribosomes prepared from
cells grown in the absence of erythromycin (Fig. 3, bottom
right) and performed primer extension. We expected to
ﬁnd the pre-rRNA in the 45S particles, but found instead
that the RNA colocalized with the 30S region of the
gradient (Fig. 4B). These results reveal yet another class
of precursor 50S particles, sedimenting with the 30S
subunits.
We were concerned that the 23S processing defects
were a result of, not a contributor to, the reduced growth
rates in the mutant strains. To test the cause–effect rela-
tionship between growth rate and rRNA processing, we
analysed the accumulation of pre-23S rRNA in wild-type
cells grown in the presence of fusidic acid. This antibiotic
interacts with the EF-G:ribosome complex to prevent
release of EF-G–GDP, thereby inhibiting protein
synthesis. At intermediate levels, the antibiotic decreases
the rate of peptide-chain elongation, resulting in slower
growth (Bennett and Maaløe, 1974). Unlike erythromycin,
fusidic acid does not bind to the ribosome, and therefore,
it should have no direct effect on ribosome biogenesis.
Fusidic acid at 50 mgm l -1 changed the doubling time of
AB301 from 28 to about 50 min, while at 100 mgm l -1, the
doubling time was further reduced to 70 min. For compari-
son, we also tested the effect of erythromycin, known to
interfere with ribosome biogenesis (Champney, 2006). An
erythromycin concentration of 50 mgm l -1 resulted in a
doubling time of about 95 min. We then extracted total
RNA from these cultures as well as the untreated cells,
and analysed the 23S content by primer extension as
explained above. We detected no signiﬁcant effect on
processing of 23S rRNA in the fusidic acid-treated cells
(Fig. 4C). Therefore, we conclude that the accumulation
of pre-23S rRNA in the ery-R mutant strains is not caused
by the reduced growth rate, but is a direct result of the
mutations’ effect on ribosome assembly. Interestingly,
erythromycin increased the pre-23S content about ﬁvefold
(Fig. 4C), indicating that the antibiotic’s effect on ribo-
some assembly (Champney, 2006) includes an inhibition
of 23S rRNA processing. A similar effect of erythromycin
on processing of 23S rRNA has been seen by S. Champ-
ney (pers. comm.).
Incorporation of mutant L4 proteins into ribosomes
To conﬁrm that the mutant L4 proteins from the ery-R
mutant strains are incorporated into ribosomes, the pres-
ence of L4 was analysed by Western analysis of crude
ribosomal pellets. We found that L4 was associated with
crude ribosomes prepared from all of the mutant strains
grown in the presence or in the absence of erythromycin
(Fig. S3). In other studies, we have observed that certain
mutant L4 proteins (not Ery-R mutations) are present in
crude ribosomes but removed during a high-salt wash
(our unpublished experiments). We reasoned that, among
the L4 mutants, the insertions were most likely to result in
an unstable association with 50S particles. Therefore,
crude ribosomes from the L4 insertion mutant strains were
salt-washed using 1 M NH4Cl buffer and analysed by
Fig. 4. Primer extension analysis of 23S rRNA in ery-R mutants.
A. Total RNA was puriﬁed from a mid-log phase culture and used
as template. A
32P-labelled oligonucleotide hybridizing internal to
the 5′ end of 23S rRNA was used as the primer for the extension
reaction. The products were analysed on a 8% acrylamide gel
together with a sequencing ladder. Precursor and mature 23S
rRNA are indicated.
B. RNA was extracted from L22-99/15 high-salt sucrose gradient
fractions (see Fig. 3) and analysed by primer extension as
described above. The AB301 lane contained RNA from a total-cell
extract.
C. RNA was extracted from cells grown in LB containing the
indicated concentration of fusidic acid or erythromycin, and
analysed as described above.
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affect the association of the mutant proteins with the ribo-
some (data not shown).
We were not able to analyse the L22 mutant strains
because we do not have an antibody that speciﬁcally
recognizes this protein.
Erythromycin binding to mutant ribosomes
Erythromycin binds to the 50S subunit in a 1:1 stoichiom-
etry in wild-type cells (Pestka, 1974). It has been shown
previously that ery-R ribosomes with a three-amino-acid
deletion in L22 (DMKR, strain N281) bind erythromycin
with high affinity, while ery-R ribosomes with a Lys-to-Glu
change at codon 63 in L4 (K63E, strain N282) show a
much reduced affinity (Wittmann et al., 1973; Chittum and
Champney, 1994). To learn more about the structures of
the mutant ribosomes, we measured their ability to bind
14C-labelled erythromycin using a nitrocellulose ﬁlter
binding assay. As expected, the canonical L4-K63E ribo-
somes (strain N282) bound erythromycin very poorly (5%
of parent AB301). Ribosomes from most of the other L4
mutants also showed little or no binding (Table 1, column
9). One surprising result was the almost normal binding of
erythromycin to ribosomes from the G66S missense
mutant (56%) (‘-Ery’ in Table 1, column 9).
Among the L22 mutants, ribosomes from the canonical
DMKR mutant (strain N281) bound erythromycin nearly as
well as AB301 (74% of wild type). Ribosomes from the
L22-105/2 insertion mutant also bound erythromycin well
(68%). However ribosomes from the L22-99/15 insertion
mutant showed reduced binding (14% of wild type)
(Table 1, column 9). Together, these binding studies indi-
cate that not all L4 mutants fail to bind erythromycin, and
not all L22 mutants bind the antibiotic well (see also
Fig. S4).
Interestingly, ribosomes which showed signiﬁcant
binding to erythromycin (L4-G66S, L22-DMKR, and L22-
105/2 and the wild-type parent AB301) also showed
reduced binding when the ribosomes were prepared from
cells grown in the presence of the antibiotic (‘+Ery’ in
Table 1, column 9; see also Fig. S4). This reduction might
result from an alteration in the structure of ribosomes
assembled in the presence of erythromycin that occludes
or distorts the antibiotic’s target. Alternatively, unlabelled
erythromycin bound to ribosomes during cell growth might
remain bound to the ribosomes even through a high-salt
centrifugation.
Discussion
We have identiﬁed new mutations in ribosomal proteins L4
and L22 that confer erythromycin resistance in E. coli. All
mutations are located in the extended loop of L4 or L22,
except for a short insertion mutation in the globular domain
of L22. Mutations in r-protein L4 were especially easy to
isolate; for example, a variety of amino acid substitutions
near the tip of the tentacle confer erythromycin resistance.
On the other hand, the variety of L22 mutations was much
morelimited,andincludedonlytwoinsertions.Althoughwe
have clearly not saturated the L4 and L22 genes for ery-R
mutations, these results are consistent with our studies of
ery-R mutants in the bacterium Deinococcus radiodurans:
inthisorganismwewerealsoabletoisolatemanymoreL4
mutants, including many missense mutations, than L22
mutants, which involved a deletion or an insertion (J.
ZengelandL.Lindahl,manuscriptinpreparation).Avariety
of L4 and L22 tentacle mutations have also been identiﬁed
in clinically relevant species of bacteria, including Haemo-
philus inﬂuenzae, Streptococcus pyogenes and S. pneu-
moniae(Franceschiet al.,2004).Manyofthesemutations,
particularly for L22, also involve insertions and deletions.
We observed that the large insertion mutations in L4
and L22 tended to revert to wild-type in the absence of
antibiotic. This phenomenon represents an interesting
paradigm for antibiotic resistance, in which cells acquire
mutations that help them survive in antibiotic medium but
then avoid the high ﬁtness cost of maintaining resistance
mutations (evident from slower growth rates) by excising
the insertion in an antibiotic-free environment. All inser-
tions consist of direct repeats of the DNAsequence, which
are removed precisely, presumably by recombination or
‘slippage’ during DNA replication or repair (Farabaugh
et al., 1978; Albertini et al., 1982). On the other hand, no
obvious repeats ﬂank the insertion sites, so it is more
difficult to speculate about the mechanism(s) creating the
insertions. However, large insertion mutants could also be
isolated in a recA mutant strain (our unpublished results),
suggesting that the insertions are formed by ‘slippage’
during DNA replication or repair rather than by homolo-
gous recombination. Reversion is not observed in minimal
media (our unpublished results), so slow-growth condi-
tions might inhibit this process, possibly because of the
lower number of genomes per cell at slow growth.
The large insertion mutant strains showed accumula-
tion of 45S particles and of pre-23S rRNA containing a
seven-nucleotide extension at the 5′ end. However, in
mutant L22-99/15, most of this pre-23S rRNA was found
in particles sedimenting at approximately 30S. Thus, it
appears that the large insertions affect at least two steps
of ribosome maturation. The failure to process pre-23S
rRNA normally may be the result of the mutated proteins
failing to shape an rRNA conformation that favours
removal of the 5′ extension. We do not know whether the
‘30S’ and 45S particles represent assembly intermediates
or, instead, ‘dead-end products’ that contain improperly
folded rRNA and/or that lack certain ribosomal proteins
whose incorporation is stimulated by L4 or L22 in the
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and 45S ribosomal particles have been reported previ-
ously in wild-type cells by pulse-labelling (Britten et al.,
1962) and in various mutants (Guthrie et al., 1969; Tai
et al., 1969); ‘30S’ particles have also been observed in
wild-type cells grown in sublethal concentrations of eryth-
romycin (Usary and Champney, 2001). More recent
experiments have shown that similar particles accumulate
in dnaK mutant cells (El Hage and Alix, 2004); those
particles could be chased into mature 50S (El Hage and
Alix, 2004), suggesting that at least some of the various
types of particles accumulating in mutant strains are
genuine precursors. On the other hand, in both the L22-
99/15 mutant and the dnaK mutant, the bulk of the pre-
23S rRNAis found in the 30S region of sucrose gradients,
while in exponentially growing wild-type E. coli, most of
pre-23S rRNA is contained in 45–50S particles (Lindahl,
1975). Perhaps there are multiple pathways for ribosome
assembly and maturation. Another possibility is that the
kinetics of certain events, such as the conversion of pre-
23S rRNA to mature 23S rRNA, are not strictly linked to
steps in the construction of ribosomal particles.
In addition to the effect on rRNA processing and ribo-
some assembly, the ribosome translation rate is also
reduced in the ery-R mutants. This observation suggests
that changes in the tunnel resulting from mutations in L4
or L22 can be transmitted to the PTC region to affect the
rate of peptide elongation. Our assay, measuring the time
after induction at which b-galactosidase activity increases,
can only reveal the elongation rate exhibited by the fastest
ribosomes in the cell. If an L4 or L22 mutation results in a
heterogeneous population of ribosomes, a fraction of the
ribosomes might translate more slowly than the rate
determined.
Our erythromycin binding assays indicate that one of
the L4 mutants (L4-66S) exhibits strong erythromycin
binding (56% of the parent), while one of the L22 mutants
(L22-99/15) does not (14% of the parent). Therefore, the
model of a narrower tunnel in L4 mutants and a widened
tunnel in L22 mutants (Gabashvili et al., 2001) is not sup-
ported by our data, at least not as a general model. If the
tunnel width is indeed affected by the L4 and L22 proteins,
the relationship is complex. A serine at position 66 of L4
behaves differently from aspartic acid, cysteine or argin-
ine at the same position. Given that these substitutions
are in a glycine, a ﬂexible amino acid close to the turn in
the L4 tentacle, these mutations could have differential
effects on L4 structure. On the other hand, all substitu-
tions in position 66 result in similar levels of erythromycin
resistance, suggesting that drug resistance can have
several different molecular explanations.
Comparison of the sucrose gradients for L4-G66C and
L22-99/15 cells grown with and without erythromycin
(Fig. 3) indicates a signiﬁcant effect of erythromycin on
ribosomal assembly. This is unexpected, because ribo-
somes from these mutants have a poor affinity for the
antibiotic. Perhaps the erythromycin binding site is acces-
sible during ribosome assembly, but after assembly is
completed, these mutations cause the site to be occluded
so that binding is not detected in the in vitro assays.
Alternatively, as suggested by Champney and coworkers
(Champney and Burdine, 1995; Usary and Champney,
2001), the binding site for erythromycin during assembly
may be different from the site in mature ribosomes. If this
is the case, then our results suggest that the former site is
less affected by mutations in L4 and L22. In any case,
there is no evidence that erythromycin interacts directly
with either protein (Schlunzen et al., 2001), so all of the
mutations presumably have an indirect effect.
The positions of the insertions into the L4 and L22
tentacles are as much as 40–70 Å from both the erythro-
mycin binding site and the PTC (Fig. 5). A secondary
cascade of modulations in the ribosome structure must
therefore cause their effect on peptide growth rate and
antibiotic binding. Direct evidence for structural modula-
tions has been observed by cryo-electron microscopy of
ribosomes from the original L4-K63E and L22-DMKR
mutants (Gabashvili et al., 2001), as well as during stall-
ing of the SecM peptide in wild-type cells in the ribosome
exit tunnel (Mitra et al., 2006). Chemical probing experi-
ments by Gregory and Dahlberg (1999) also identiﬁed
perturbations in the rRNA structures in L4-K63E and L22-
DMKR ribosomes. Therefore, it is not surprising that
similar effects might emanate from our new mutations in
Fig. 5. Model of the L4 and L22 tentacles and key nucleotides in
the PTC and PTC-proximal region of the tunnel. The backbones of
the L4 (red) and L22 (green) tentacles are shown. Positions of
point mutations, insertions and deletions are indicated in yellow for
L4 and black for L22. Nucleotides are shown in blue. A2058 and
A2059 are located the beginning of the tunnel and form part of the
binding site for erythromycin and other macrolides. A2450 and
A2451 are key nucleotides in the PTC (Nissen et al., 2000; Hansen
et al., 2002b). The model was drafted using RasMol and PDB
structure 2I2T (Berk et al., 2006).
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insertions. For example, L22 is a small, 110-amino-acid
protein, so a 45 bp insertion mutation signiﬁes a signiﬁ-
cant increase in its size. The variations in the ribosome
properties observed in our mutants suggest that these
cascades of structural modiﬁcations can play out in differ-
ent ways. Chemical probing or other structure analysis will
be required to determine how this extra bulk in the L22
and L4 proteins affects the rRNA structure.
Experimental procedures
Isolation of ery-R mutants
The wild-type strain used in this study is E. coli strain AB301
(A19 Hfr met
–). Erythromycin-resistant strains N281 and
N282, carrying mutations in r-proteins L22 and L4 respec-
tively, have been described previously (Wittmann et al., 1973;
Chittum and Champney, 1994). The minimal inhibitory con-
centration of erythromycin for AB301 was determined to be
150 mgm l
-1. In the ﬁrst selection, a single colony from strain
AB301 was used to inoculate LB broth.After overnight growth
at 37°C, 0.1 ml aliquots was plated on LB agar + 150 or
200 mgm l
-1 erythromycin (Sigma) and incubated at 37°C for
up to 5 days. In a second selection, strain AB301 was plated
on LB-agar plates without erythromycin. The single colonies
obtained were grown in 0.3 ml LB broth (without erythromy-
cin) in a 24-well plate (one colony per well). Approximately
0.1 ml from each well was plated on LB + 150 mgm l
-1
erythromycin. If more than one mutant grew on a plate, only
one was repuriﬁed. The latter selection protocol ensured that
independent mutants were isolated.
Polymerase chain reaction (PCR) ampliﬁcation and
DNA sequencing
The L4 and L22 genes (rplD and rplV, respectively) from
ery-R colonies were ampliﬁed by colony PCR using primers
O1462 (5′-CTGGTTAAAGGTGCTGTCC-3′) and O1455
(5′-CCATCGCAGTAGACGCTT-3′) to amplify the L4 gene,
and primers O1460 (5′-GAATTCGCACCGACTCGTAC-3′)
and O1461 (5′-GGTGTTCGCAAAGGTGCTGTCCC-3′)t o
amplify the L22 gene. PCR products were puriﬁed using a
Qiaquick PCR puriﬁcation kit (Qiagen) and sequenced with
the ABI Big Dye terminator sequencing kit using primers
O1462 and O1460. To conﬁrm that the identiﬁed changes in
the L4 or L22 genes were responsible for the mutants’ phe-
notypes, we ampliﬁed the relevant gene and, by recom-
bineering, introduced the DNA into one or more other hosts.
For all of the mutations, the resulting strains maintained the
phenotypic properties of the original mutants (M. Lawrence
and J.M. Zengel, data not shown).
Analysis of erythromycin, spiramycin and
tylosin resistance
To determine the mutants’ level of resistance to erythromycin,
spiramycin and tylosin, AB301, N281, N282 and the new
ery-R mutants were streaked onto LB-agar plates supple-
mented with various amounts of the antibiotics. Plates were
incubated at 37°C for 2 days before growth was scored.
Growth rate assay and identiﬁcation of revertants
Growthratesweremeasuredforcellsgrowingexponentiallyat
37°C. For growth rates measured in the presence of erythro-
mycin, mutant strains were grown in LB containing erythromy-
cin at the same concentration as that at which they were
isolated (150 or 200 mgm l
-1). For growth rates measured in
the absence of erythromycin, non-reverting strains (missense
and short insert mutants) were grown in LB without erythro-
mycin. Reverting strains were grown in LB + erythromycin.
When the density reached OD450 = 1.0–1.2 (approximately
2 ¥ 10
8cellsperml),theculturewasﬁlteredthrougha0.22 mm
cellulose acetate ﬁlter (Corning). The trapped cells were
washed twice with prewarmed LB without erythromycin,
resuspended in sixfold the original culture volume LB without
erythromycin (prewarmed), and incubated again at 37°C.
Revertants were identiﬁed by streaking strains on LB and
LB + erythromycin(150or200 mgm l
-1)plates.TheL4andL22
genes from single colonies were ampliﬁed by colony PCR and
sequenced as described above.
Ribosome preparation
Non-reverting strains were grown at 37°C in LB with or
without erythromycin. Reverting strains were grown with
erythromycin or in a ‘chase’ experiment as described above.
When the cultures reached OD450 = 1.5–2.0 (mid-log phase),
cells were harvested by pouring onto ice and pelleting at 8K
for 10 min. Cells were resuspended in buffer A (20 mM
HEPES-KOH pH 7.5, 6 mM MgCl2,3 0 m MN H 4Cl, 6 mM
b-mercaptoethanol) and lysed using the slow-thaw lysozyme
method (Zengel et al., 2003). Cell debris was removed by
spinning at 22K for 30 min, and the supernatant was used as
the crude cell lysate. The cell lysate was spun at 50K for 4 h
to pellet crude ribosomes. Ribosome pellets were washed
with bufferAand resuspended overnight in 200 ml bufferA. To
prepare salt-washed ribosomes, 100 ml of crude ribosomes
was added to 0.9 ml salt wash buffer (20 mM HEPES-KOH
pH 7.5, 30 mM MgCl2,1MN H 4Cl, 6 mM b-mercaptoethanol),
incubated for 1 h on ice, spun at 50K for 4 h, and resus-
pended as for crude ribosomes.
Erythromycin binding
Erythromycin binding assays were performed by the method
of Teraoka (1970). Brieﬂy, ribosomes (2.5 A260 units) were
incubated at 37° for 15 min with 2–5 ml of a 1:100 dilution of
[N-methyl-
14C]-erythromycin (New England Nuclear; 55 mCi-
mmol
-1; 100 mCi ml
-1) in erythromycin binding buffer (50 mM
Tris-HCl pH 7.8; 16 mM Mg acetate; 60 mM KCl; 100 ml ﬁnal
volume). Each reaction contained 36–90 pmol erythromycin
and 50–60 pmole ribosomes [assuming 1 mg ml
-1E. coli ribo-
somes corresponds to 18 A260 (Haselkorn et al., 1963)]. The
assay mix was poured through a 0.45 mm nitrocellulose ﬁlter
(Millipore). Filters were washed three times, each with 2 ml
erythromycin wash buffer (25 mM Tris-HCl pH 7.8, 20 mM
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mycin bound to the ribosomes was measured by liquid
scintillation counting of the ﬁlters (Beckman-Coulter LS
6500). Assays were always carried out in duplicate or
triplicate.
Induction of b-galactosidase
The kinetics of induction of b- galactosidase were determined
as described (Zengel et al., 1977). Brieﬂy, cultures were
grown at 30°C inAB minimal media (Clark and Maaløe, 1967)
supplemented with glycerol (0.4%), thiamine (1 mgm l
-1) and
casamino acids (0.1%). At OD450 between 0.2 and 0.45, the
gratuitous inducer IPTG was added to a ﬁnal concentration of
1 mM. Samples were removed at various times after addition
of IPTG and mixed immediately with Z buffer (Miller, 1972)
plus 50 ml 1% deoxycholate, 10 ml chloramphenicol
(10 mg ml
-1 in ethanol) and 40 ml toluene at 0°C (total volume
1 ml). After evaporation of toluene and ethanol, the
b-galactosidase activity was measured as hydrolysis of
o-nitrophenyl-b-D-galactoside according to the procedure of
Miller (1972).
Sucrose gradient sedimentation
Crude ribosomes (10 A260 units) were incubated at 0°C
for 45 min in 2¥ to 10¥ volume buffer A-3 (20 mM HEPES-
KOH pH 7.5, 1 mM MgCl2, 200 mM NH4Cl, 6 mM
b-mercaptoethanol), loaded on top of 10–50% sucrose gra-
dients in buffer A-3, and centrifuged at 4°C for 16 h at
24 500 r.p.m. Fractions were collected using an ISCO
sucrose gradient collector with a UV monitor.
Primer extension
Total RNA was isolated by the hot phenol method from cul-
tures grown to mid-log phase (Zengel et al., 1990). Primers
hybridizing ~75 nt internal to the 5′ end of mature 23S rRNA
were end-labelled with [g-
32P]-ATP by T4 kinase using stan-
dard protocols (Sambrook et al., 1989). Radiolabelled primer
(10
6 cpm) was mixed with 5 mg ethanol-precipitated RNA in
0.5 M Tris-HCl pH 8/1 M KCl buffer, incubated at 90°C for
1 min, and slowly cooled to room temperature. The RNA–
primer mixture was mixed with First Strand Buffer (Invitro-
gen), 6.5 mM dithiothreitol, 0.1 mM deoxyribonucleoside
triphosphates, 10 U ribonuclease inhibitor (Fermentas) and
200 U Superscript III Reverse Transcriptase (Invitrogen), and
incubated at room temperature for 5 min and then at 50°C
for 45 min. Reactions were terminated by the addition of
2 ml 0.25 M EDTA, extracted using 1:1 phenol/chloroform/
isoamylalcohol, followed by chloroform extraction, ethanol
precipitated, and resuspended in 4 mlH 2O. RNA loading
buffer (4 ml) was added and the sample was heated at 70°C
for 4 min. A 4 ml aliquot was analysed by electrophoresis on
an 8% sequencing gel. For size markers, a sequencing
ladder was run alongside the samples. To quantify the radio-
activity in bands representing mature and pre-23S rRNAs,
the gel was dried using a vacuum blotter at 76°C for 2 h and
analysed on a phosphorimager (Molecular Dynamics).
RNA was extracted from 0.5 ml sucrose gradient fractions
by phenol extraction and ethanol precipitation, and analysed
by primer extension as described above.
Western analysis
Crude and salt-washed ribosomes (0.33 A260 units) were frac-
tionated by 12% SDS-PAGE (Laemmli, 1970) and subjected
to Western analysis as described (Zengel et al., 2003). Pre-
stained molecular weight markers (Fermentas PAGE Ruler)
were used. For probing L4, a rabbit polyclonal antibody spe-
ciﬁc for E. coli L4 (a gift from M. Nomura, diluted 1:10 000)
was used as the primary antibody. An alkaline phosphatase-
conjugated goat-anti rabbit IgG (Bio-Rad, diluted 1:3000) was
used as the secondary antibody. The signal was detected by
chemiluminescence using the CDP-STAR substrate (Sigma-
Aldrich).
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